RxDoctor Payments Data

Hassan Malik

Internal Medicine · Akron, OHNPI 1407876220

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,694,126 of the $1,694,286 with a category attached, or 100.0%. Otsuka Pharmaceutical Development & Commercialization, Inc. accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $401,034 and has fallen 87.8% since, to $49,100 in 2025. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,694,286in general payments, 2019–2025

Across 78 payments — averaging $21,722 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1.7M
  • Pfizer$145
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$15

What the payments were for

  • Consulting fees$1,694,126100%
  • Food & beverage$1600%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,694,286 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Other internal medicine in Akron

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →